2004

2月19日，bat365中文官方网站成立

On February 19, Ningbo Menovo Pharmaceutical Co.,Ltd. was set up.

7月13日，成立bat365中文官方网站藥物化學有限公司

On July 13, Anhui Menovo Pharmaceutical Co.,Ltd. was set up.

2005

11月17日，成立bat365中文官方网站藥物化學有限公司

On November 17, Zhejiang Menovo Pharmaceutical Co.,Ltd. was set up.

2007

5月22日，成立甯波聯華進出口有限公司

On May 22, Ningbo Lianhua Import & Export Co.,Ltd. was set up.

2009

11月，成立香港聯合億貿進出口有限公司

In November, Hongkong United Billion Trade Import And Export Co.,Ltd. was set up.

2010

11月18日，成立甯波bat365中文官方网站藥業有限公司

On November 18, Ningbo Menovo Tiankang Pharmaceutical Co.,Ltd. was set up.

2012

4月6日，成立上海新五洲藥業有限公司

On April 6, Shanghai New International Pharmaceutical Co.,Ltd. was set up.

7月31日，成立杭州新諾華醫藥有限公司

On July 31, Hangzhou Sinovo Medicine Co.,Ltd. was set up.

2013

11月8日，美諾華藥物研究院組建成立

On November 8, Menovo R&D Center was set up.

2014

3月18日，參股浙江瑞邦藥業股份有限公司

On March 18, the company took a stake in Zhejiang Ruibang Pharmaceutical Co.,Ltd.

4月，參股浙江博騰藥業有限公司

In April, the company took a stake in Zhejiang Porton Pharmaceutical Co.,Ltd.

2015

5月15日，成立bat365中文官方网站藥業有限公司

On May 15, Xuancheng Menovo Pharmaceutical Co.,Ltd. was set up.

9月，成立印度柏萊諾華藥業有限公司

In September, Biomenovo Researce Private Limited was set up.

2017

4月7日，美諾華在上交所A股上市

On April 7, Menovo listed on Shanghai Stock Exchange.

11月1日，美諾華正式控股浙江燎原藥業股份有限公司

On November 1, Menovo controlled Zhejiang Liaoyuan Pharmaceutical Co.,Ltd.

11月15日，成立甯波科爾康美諾華藥業股份有限公司

On November 15, Ningbo Krka Menovo Pharmaceutical Co.,Ltd. was set up.

2018

4月11日，與上海銳合資産管理有限公司等四家簽署合作協議參股“甯波美諾華銳合股權投資合夥企業（有限合夥）”

On April 11, the company signed cooperation agreements with Shanghai Ruihe Asset Management Co.,Ltd and other four companies to participate in the “Ningbo Menovo Ruihe Equity Investment Partnership (limited partnership)”.

2020

3月16日，成立甯波美諾華醫藥科技有限公司

On March 16, Ningbo Menovo Pharmaceutical Technology Co.,Ltd. was set up.

7月30日，收購甯波高新區美諾華醫藥創新研究院有限公司100%股權

On July 30, it acquired 100% of the equity of Ningbo high tech Zone Menovo Pharmaceutical Innovation Research Institute Co., Ltd.